These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597 [TBL] [Abstract][Full Text] [Related]
5. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244 [TBL] [Abstract][Full Text] [Related]
6. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Schwarz A; Merkel S; Leitolf H; Haller H Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318 [TBL] [Abstract][Full Text] [Related]
7. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463 [TBL] [Abstract][Full Text] [Related]
8. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism. Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956 [TBL] [Abstract][Full Text] [Related]